Definium’s late-stage pipeline includes four Phase 3 trials—two each for GAD and MDD—anchored by its lead candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD.

Platforms such as Tron are reinforcing their position as the base layer for stablecoin settlement and trading, which is now ...

Stranger Things is now moving into a new era with the original show concluded, but there's a problem with its next project.

The new IQ9N-3P microinverter utilizes gallium nitride technology to deliver 427 VA of peak power and 97.5% efficiency for the 480 V three-phase commercial market.

The new IQ9N-3P microinverter utilizes gallium nitride technology to deliver 427 VA of peak power and 97.5% efficiency for the 480 V three-phase commercial market.

Enphase Energy started shipping its IQ9N-3P Commercial Microinverter across the United States in late December 2025. The ...

Larimar Therapeutics is deeply undervalued, trading at ~$3.40 despite a de-risked safety profile and a clear regulatory path ...

Nurix advances CLL therapy with NX-5948 showing 83% response, 22.1-month PFS, $680M cash, and $3B risk-adjusted sales ...

Despite being in a transitional phase following the departure of longtime international scouting director Donny Rowland and ...

India's fourth-largest IT services firm Wipro forecast weaker-than-expected revenue growth for the current quarter on Friday ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

Celtics trade Sam Hauser, Chris Boucher, their 2026 1st and 2 future seconds for Wendell Carter Jr. Orlando gets some much ...